Work

1204 A Phase I study evaluating the pharmacokinetics (PK) and pharmacodynamics (PD) of the oral pan-phosphoinositide-3 kinase (PI3K) inhibitor GDC-0941

Year: 2009

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(09)70416-1

Authors: R. Kristeleit, D. Sarker, M. Forster, M. Lolkema, D. Olmos, K. Mazina, M.V. Dolezal, J.A. Ware, Y. Yan, J.S. de Bono

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1970418107

Cites:

Cited by: 6

Related to: 10